Alnylam Pharmaceuticals
ALNY
#852
Rank
ยฃ22.46 B
Marketcap
ยฃ167.87
Share price
1.19%
Change (1 day)
-46.95%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company